Tear replacement by cationic emulsion in complex therapy of superficial punctate keratitis in hypotensively medicated glaucoma patients

Purpose. To evaluate the efficacy of lubricating cationic emulsion in the combined treatment of superficial punctate keratitis (SPK) of glaucoma patients. Material and methods. The clinical study involved an experimental group 1 of 28 patients (30 eyes) aged 50 to 84 (mean age 67.1 ± 7.2 years) with...

Full description

Bibliographic Details
Main Authors: S. V. Trufanov, S. A. Malozhen, D. A. Krakhmaleva, E. A. Pivin
Format: Article
Language:Russian
Published: Real Time Ltd 2018-10-01
Series:Российский офтальмологический журнал
Subjects:
Online Access:https://roj.igb.ru/jour/article/view/59
id doaj-8e0b82211ff8442b834fc7a51475cd04
record_format Article
spelling doaj-8e0b82211ff8442b834fc7a51475cd042021-07-28T13:01:38ZrusReal Time LtdРоссийский офтальмологический журнал2072-00762587-57602018-10-0194525710.21516/2072-0076-2016-9-4-52-5759Tear replacement by cationic emulsion in complex therapy of superficial punctate keratitis in hypotensively medicated glaucoma patientsS. V. Trufanov0S. A. Malozhen1D. A. Krakhmaleva2E. A. Pivin3Research Institute of Eye DiseasesResearch Institute of Eye DiseasesResearch Institute of Eye DiseasesResearch Institute of Eye DiseasesPurpose. To evaluate the efficacy of lubricating cationic emulsion in the combined treatment of superficial punctate keratitis (SPK) of glaucoma patients. Material and methods. The clinical study involved an experimental group 1 of 28 patients (30 eyes) aged 50 to 84 (mean age 67.1 ± 7.2 years) with symptoms of SPK who received long-term (averagely 9.5 ± 6.6 years) topical hypotensive anti-glaucoma medication. The control group 2 consisted of 26 patients (mean age 67.6 ± 7.1 years) belonging to the experimental group: in this case, the contralateral eyes with topical anti glaucoma medication but no signs of keratitis were examined. The basic therapy for group 1 consisted of topical antihistamine, corneoprotector (dexpanthenol) and a new generation lubricant, Cationorm. Group 2 was also treated with Cationorm. The testing procedures and efficiency monitoring included biomicroscopy, Schirmer test, Norn test and evaluation of tear film osmolarity. Results. Dry eye symptoms with disturbed tear film osmolarity and decreased values of Norn and Schirmer tests were detected in all patients both in the eyes with SPK manifestations and without them. Patients with concomitant dry eye syndrome who received complex therapy, including Cationorm, showed increased tear film stability: Norn sample values increased from 5.5 ± 1.8 to 8.5 ± 2.1 seconds and from 7.7 ± 1.4 to 8.8 ± 2.2 seconds in groups 1 and 2, respectively, p < 0.05). Besides, the values of the Schirmer test improved from 6.3 ± 2.1 to 8.3 ± 3.7 mm and 8.7 ± 3.7 to 9.1 ± 3.8 mm in groups 1 and 2, respectively, p < 0.05), and osmolarityrate decreased in both groups, p < 0.05. Subjective symptoms in group 1 changed from 3.4 to 0.6 points after 3 months of treatment. The average severity of SPK, which amounted to 4.2 ± 2.3 points before treatment, dropped to 1.2 ± 0.9, 0.23 ± 0.5 and 0.1 ± 0.3 points respectively after 1, 2 and 3 months. Conclusion. The study shows that Cationorm can be considered as a tear replacement lubricant of choice in the complex therapy of superficial punctate keratitis and dry eye symptoms in chronically medicated glaucoma patients // Russian Ophthalmological Journal, 2016; 4: 52-7. doi: 10.21516/2072-0076-2016-9-4-52-57.https://roj.igb.ru/jour/article/view/59поверхностный точечный кератитсиндром «сухого глаза»глаукомаконсервантытест ширмерапроба норнаосмолярометриякератопротекторыслезозаместительная терапиякатионормsuperficial punctate keratitisdry eye syndromeglaucomapreservativesschirmer testnorn testtear film osmolaritycationorm
collection DOAJ
language Russian
format Article
sources DOAJ
author S. V. Trufanov
S. A. Malozhen
D. A. Krakhmaleva
E. A. Pivin
spellingShingle S. V. Trufanov
S. A. Malozhen
D. A. Krakhmaleva
E. A. Pivin
Tear replacement by cationic emulsion in complex therapy of superficial punctate keratitis in hypotensively medicated glaucoma patients
Российский офтальмологический журнал
поверхностный точечный кератит
синдром «сухого глаза»
глаукома
консерванты
тест ширмера
проба норна
осмолярометрия
кератопротекторы
слезозаместительная терапия
катионорм
superficial punctate keratitis
dry eye syndrome
glaucoma
preservatives
schirmer test
norn test
tear film osmolarity
cationorm
author_facet S. V. Trufanov
S. A. Malozhen
D. A. Krakhmaleva
E. A. Pivin
author_sort S. V. Trufanov
title Tear replacement by cationic emulsion in complex therapy of superficial punctate keratitis in hypotensively medicated glaucoma patients
title_short Tear replacement by cationic emulsion in complex therapy of superficial punctate keratitis in hypotensively medicated glaucoma patients
title_full Tear replacement by cationic emulsion in complex therapy of superficial punctate keratitis in hypotensively medicated glaucoma patients
title_fullStr Tear replacement by cationic emulsion in complex therapy of superficial punctate keratitis in hypotensively medicated glaucoma patients
title_full_unstemmed Tear replacement by cationic emulsion in complex therapy of superficial punctate keratitis in hypotensively medicated glaucoma patients
title_sort tear replacement by cationic emulsion in complex therapy of superficial punctate keratitis in hypotensively medicated glaucoma patients
publisher Real Time Ltd
series Российский офтальмологический журнал
issn 2072-0076
2587-5760
publishDate 2018-10-01
description Purpose. To evaluate the efficacy of lubricating cationic emulsion in the combined treatment of superficial punctate keratitis (SPK) of glaucoma patients. Material and methods. The clinical study involved an experimental group 1 of 28 patients (30 eyes) aged 50 to 84 (mean age 67.1 ± 7.2 years) with symptoms of SPK who received long-term (averagely 9.5 ± 6.6 years) topical hypotensive anti-glaucoma medication. The control group 2 consisted of 26 patients (mean age 67.6 ± 7.1 years) belonging to the experimental group: in this case, the contralateral eyes with topical anti glaucoma medication but no signs of keratitis were examined. The basic therapy for group 1 consisted of topical antihistamine, corneoprotector (dexpanthenol) and a new generation lubricant, Cationorm. Group 2 was also treated with Cationorm. The testing procedures and efficiency monitoring included biomicroscopy, Schirmer test, Norn test and evaluation of tear film osmolarity. Results. Dry eye symptoms with disturbed tear film osmolarity and decreased values of Norn and Schirmer tests were detected in all patients both in the eyes with SPK manifestations and without them. Patients with concomitant dry eye syndrome who received complex therapy, including Cationorm, showed increased tear film stability: Norn sample values increased from 5.5 ± 1.8 to 8.5 ± 2.1 seconds and from 7.7 ± 1.4 to 8.8 ± 2.2 seconds in groups 1 and 2, respectively, p < 0.05). Besides, the values of the Schirmer test improved from 6.3 ± 2.1 to 8.3 ± 3.7 mm and 8.7 ± 3.7 to 9.1 ± 3.8 mm in groups 1 and 2, respectively, p < 0.05), and osmolarityrate decreased in both groups, p < 0.05. Subjective symptoms in group 1 changed from 3.4 to 0.6 points after 3 months of treatment. The average severity of SPK, which amounted to 4.2 ± 2.3 points before treatment, dropped to 1.2 ± 0.9, 0.23 ± 0.5 and 0.1 ± 0.3 points respectively after 1, 2 and 3 months. Conclusion. The study shows that Cationorm can be considered as a tear replacement lubricant of choice in the complex therapy of superficial punctate keratitis and dry eye symptoms in chronically medicated glaucoma patients // Russian Ophthalmological Journal, 2016; 4: 52-7. doi: 10.21516/2072-0076-2016-9-4-52-57.
topic поверхностный точечный кератит
синдром «сухого глаза»
глаукома
консерванты
тест ширмера
проба норна
осмолярометрия
кератопротекторы
слезозаместительная терапия
катионорм
superficial punctate keratitis
dry eye syndrome
glaucoma
preservatives
schirmer test
norn test
tear film osmolarity
cationorm
url https://roj.igb.ru/jour/article/view/59
work_keys_str_mv AT svtrufanov tearreplacementbycationicemulsionincomplextherapyofsuperficialpunctatekeratitisinhypotensivelymedicatedglaucomapatients
AT samalozhen tearreplacementbycationicemulsionincomplextherapyofsuperficialpunctatekeratitisinhypotensivelymedicatedglaucomapatients
AT dakrakhmaleva tearreplacementbycationicemulsionincomplextherapyofsuperficialpunctatekeratitisinhypotensivelymedicatedglaucomapatients
AT eapivin tearreplacementbycationicemulsionincomplextherapyofsuperficialpunctatekeratitisinhypotensivelymedicatedglaucomapatients
_version_ 1721277347940794368